V

Vectus Biosystems Ltd
ASX:VBS

Watchlist Manager
Vectus Biosystems Ltd
ASX:VBS
Watchlist
Price: 0.175 AUD 59.09%
Market Cap: 9.3m AUD

Net Margin
Vectus Biosystems Ltd

-9 453.7%
Current
-581 802.1%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9 453.7%
=
Net Income
-1.8m
/
Revenue
18.8k

Net Margin Across Competitors

No Stocks Found

Vectus Biosystems Ltd
Glance View

Market Cap
9.3m AUD
Industry
Biotechnology

Vectus Biosystems Ltd. operates as a drug discovery and development company. The company is headquartered in Rosebery, New South Wales. The company went IPO on 2016-02-23. The firm has developed treatments for fibrosis and high blood pressure, which include treatment for four of the diseases in the fibrotic franchise, namely heart, kidney, liver and lung disease. Its lead compound VB0004, which is aimed at treating the loss of functional tissue to fibrosis or scarring and high blood pressure. The firm has also developed a technology, Accugen for measuring the amount of Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Using its platform technology, the Company has constructed a library of approximately 200 small molecules with varying degrees of anti-hypertensive and anti-fibrotic properties. Accugen is developed by the Company's subsidiary, Accugen Pty Limited. Accugen comprises reagents and software that quantitate quantitative polymerase chain reaction (qPCR) reactions.

VBS Intrinsic Value
0.004 AUD
Overvaluation 98%
Intrinsic Value
Price
V
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-9 453.7%
=
Net Income
-1.8m
/
Revenue
18.8k
What is the Net Margin of Vectus Biosystems Ltd?

Based on Vectus Biosystems Ltd's most recent financial statements, the company has Net Margin of -9 453.7%.

Back to Top